Vivid Seats Inc.
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
SEAT$2.09-23.7%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FINANCIAL INFORMATION
| March 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $199,471 | $243,482 |
| Restricted cash | 1,222 | 1,166 |
| Accounts receivable – net | 56,862 | 48,315 |
| Inventory – net | 27,653 | 19,601 |
| Prepaid expenses and other current assets | 34,582 | 32,607 |
| Total current assets | 319,790 | 345,171 |
| Property and equipment – net | 13,815 | 12,567 |
| Right-of-use assets – net | 11,748 | 12,008 |
| Intangible assets – net | 228,057 | 233,116 |
| Goodwill – net | 945,301 | 943,119 |
| Deferred tax assets – net | 74,318 | 77,967 |
| Investments | 6,713 | 6,929 |
| Other assets | 5,796 | 5,219 |
| Total assets | $1,605,538 | $1,636,096 |
| Liabilities, redeemable noncontrolling interests, and shareholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $226,416 | $232,984 |
| Accrued expenses and other current liabilities | 162,801 | 165,047 |
| Deferred revenue | 23,113 | 23,804 |
| Current maturities of long-term debt | 3,950 | 3,950 |
| Total current liabilities | 416,280 | 425,785 |
| Long-term debt – net | 385,788 | 384,960 |
| Long-term lease liabilities | 18,217 | 18,731 |
| TRA liability | 149,967 | 155,720 |
| Other liabilities | 28,945 | 36,865 |
| Total liabilities | 999,197 | 1,022,061 |
| Commitments and contingencies (Note 13) | ||
| Redeemable noncontrolling interests | 225,627 | 352,922 |
| Shareholders' equity: | ||
| Class A common stock, $0.0001 par value; 500,000,000 shares authorized, 146,230,980 and 143,819,497 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 14 | 14 |
| Class B common stock, $0.0001 par value; 250,000,000 shares authorized, 76,225,000 shares issued and outstanding at March 31, 2025 and December 31, 2024 | 8 | 8 |
| Additional paid-in capital | 1,399,423 | 1,267,710 |
| Treasury stock, at cost, 13,812,263 and 11,433,749 shares at March 31, 2025 and December 31, 2024, respectively | (82,485) | (75,568) |
| Accumulated deficit | (936,113) | (930,171) |
| Accumulated other comprehensive loss | (133) | (880) |
| Total shareholders' equity | 380,714 | 261,113 |
| Total liabilities, redeemable noncontrolling interests, and shareholders' equity | $1,605,538 | $1,636,096 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data) (Unaudited)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.